Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
MIV-802 has been selected as a candidate drug and enters non-clinical development for the treatment of hepatitis C infection
Monday, December 22, 2014Medivir AB announced that MIV has been selected as a candidate drug CD from its hepatitis C virus HCV nucleotide polymerase inhibitor project for the treatment of HCV infection and is entering nonclinical development Approximately million people a...
Swissmedic approves Basilea''s antibiotic Zevtera(r) (ceftobiprole medocaril) for the treatment of pneumonia
Monday, December 22, 2014Basilea Pharmaceutica Ltd reports that the Swiss regulatory authority Swissmedic has approved the antibiotic Zevtera ceftobiprole medocaril for the treatment in adults of communityacquired pneumonia CAP and hospitalacquired pneumonia HAP excluding ve...
Roche to pay up to $489 mln for next-generation antibody developer Dutalys
Saturday, December 20, 2014Roche has agreed to pay up to million to acquire Austrian biotech company Dutalys a specialist in the discovery and development of socalled bispecific antibodies the Swiss drugmaker said on Thursday Bispecific antibody therapy is a fastemerging te...
Lifeline Pharmaceuticals Announces New Mississippi Distribution Center
Friday, December 19, 2014After years of successive growth Lifeline Pharmaceuticals a Floridabased pharmaceuticals wholesale distribution company has invested in additional distribution capacity in the state of Mississippi The new distribution center scheduled to open duri...
Dr. Reddys Laboratories closes the acquisition of Habitrol Brand from Novartis
Friday, December 19, 2014Dr Reddys Laboratories has announced that it has closed the acquisition of Habitrol brand an overthecounter nicotine replacement therapy transdermal patch from Novartis Consumer Health Inc following issuance of the proposed consent order from the US...
Veridicus Health acquires St. Louis based Global Pharmaceutical Solutions
Thursday, December 18, 2014Veridicus Health a provider of comprehensive and customizable pharmacy and care management solutions announces the acquisition of St Louis Missouri based Global Pharmaceutical Solutions GPS Dr Douglas Burgoyne PharmD CEO of Veridicus Health made the...
Shire considering bid for NPS Pharmaceuticals
Thursday, December 18, 2014Dublinbased Shire Plc whose proposed sale to AbbVie Inc fell apart in October is considering an offer for USbased drug developer NPS Pharmaceuticals Inc Bloomberg reported citing people familiar with the matter NPSs shares rose as much as percent...
Poxel announces Positive Top Line Results for Its Antidiabetic Agent Imeglimin in a Phase 2b Dose-Ranging Trial
Wednesday, December 17, 2014Poxel SA today announced that Imeglimin a novel compound in development to treat Type Diabetes demonstrated dosedependent efficacy on two key measures of diabetes control in a phase b trial conducted in both treatmentnave patients and patients pre...
POZENs YOSPRALA receives Complete Response Letter from The FDA
Wednesday, December 17, 2014POZEN Inc a pharmaceutical company committed to transforming medicine that transforms lives announced today that their investigational drug candidates YOSPRALA and aspirin omeprazole delayed release tablets have received a second complete response...
OPKO and Pfizer Enter into Global Agreement for OPKOs Long-Acting Human Growth Hormone (hGH-CTP)
Tuesday, December 16, 2014OPKO Health Inc and Pfizer Inc announced today that they have entered into a worldwide agreement for the development and commercialization of OPKOs longacting hGHCTP for the treatment of growth hormone deficiency GHD in adults and children as well as...
